Novel biomarkers in major depression
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: This article reviews literature published over the period January 2011-June 2012 on biomarkers in major depression. RECENT FINDINGS: Although a large body of research accumulated over the past decades points to distinct biological mechanisms being involved in the pathophysiology of major depressive disorder (MDD), its precise pathobiology is not yet fully understood. In the last 2 years, substantial new research has been generated in an attempt to identify and characterize novel candidate biomarkers for MDD. This review provides an update on biomarker research in MDD and summarizes the most recent results from neuroimaging, genetic, epigenetic, and neurochemical studies in MDD. SUMMARY: Promising new findings report high diagnostic accuracy for metabonomic and epigenetic approaches as well as combinatorial functional neuroimaging approaches, which are currently representing the forefront of MDD biomarker development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Kempton, M. J., Salvador, Z., Munafò, M. R., Geddes, J. R., Simmons, A., Frangou, S., & Williams, S. C. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.60 · Cited by 886
Zeng, L.-L., Shen, H., Liu, L., Wang, L., Li, B., Fang, P., Zhou, Z., Li, Y., & Hu, D. (2012) · Brain · doi:10.1093/brain/aws059 · Cited by 748
Zhu, X., Wang, X., Xiao, J., Liao, J., Zhong, M., Wang, W., & Yao, S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.035 · Cited by 638
Wray, N. R., Pergadia, M. L., Blackwood, D. H. R., Penninx, B. W. J. H., Gordon, S. D., Nyholt, D. R., Ripke, S., MacIntyre, D. J., McGhee, K. A., Maclean, A. W., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.109 · Cited by 444
Molendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Kenis, G., Prickaerts, J., Voshaar, R. O., & Elzinga, B. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.98 · Cited by 437 · cited 2×
“BDNF has been suggested as a final common pathway for various and seemingly unrelated antidepressant therapeutic approaches, which all seem to result in normalized BDNF levels in MDD patients after treatment [8,9].”
BackgroundResultFrodl, T., Schüle, C., Schmitt, G., Born, C., Baghai, T., Zill, P., Bottlender, R., Rupprecht, R., Bondy, B., Reiser, M., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.410 · Cited by 394
Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023881 · Cited by 378
Cole, J., Costafreda, S. G., McGuffin, P., & Fu, C. H. Y. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.057 · Cited by 319
Cited by
Bhaumik, R., Jenkins, L. M., Gowins, J. R., Jacobs, R. H., Barba, A., Bhaumik, D. K., & Langenecker, S. A. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.02.018 · Cited by 72
“However, there is substantial interest in identifying single subject biomarkers that are clinically applicable as diagnostic or prognostic tools (Mossner et al., 2007; Atluri et al., 2013; Schneider and Prvulovic, 2013).”
BackgroundInterleukin-6 and Interleukin-10 in Mood Disorders: A Population-Based Study
Wiener, C. D., Moreira, F. P., Portela, L. V., Strogulski, N. R., Lara, D. R., da Silva, R. A., Souza, L. D. D. M., Jansen, K., & Oses, J. P. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.01.100 · Cited by 68
Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial
Del Grande da Silva, G., Wiener, C. D., Barbosa, L. P., Gonçalves Araujo, J. M., Molina, M. L., San Martin, P., Oses, J. P., Jansen, K., Dias de Mattos Souza, L., & Azevedo da Silva, R. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.01.008 · Cited by 60
Na, K.-S., Won, E., Kang, J., Kim, A., Choi, S., Tae, W.-S., Kim, Y.-K., Lee, M.-S., Joe, S.-H., & Ham, B.-J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.030 · Cited by 50
Combined cognitive, psychomotor and electrophysiological biomarkers in major depressive disorder
Koo, P. C., Berger, C., Kronenberg, G., Bartz, J., Wybitul, P., Reis, O., & Hoeppner, J. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0952-9 · Cited by 45
Metadata
- Authors
- Schneider, B., & Prvulovic, D.
- Venue
- Current Opinion in Psychiatry
- Published
- 2013-01
- Volume
- 26
- Issue
- 1
- Pages
- 47-53
- ISSN
- 0951-7367 (ISSN-L)
- OpenAlex
- W2093369439
- Cited by
- 65
- References
- 21
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel biomarkers in major depression. https://app.cochat.ai/papers/10.1097/yco.0b013e32835a5947
- The paper
- Schneider, B., & Prvulovic, D. (2013). Novel biomarkers in major depression. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e32835a5947
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.